Archer Investment Corporation’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Archer Investment Corporation’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300	Closed	-$24	–	918
2022 Q4	$24	Hold	300	–	–	﹤0.01%	825
2022 Q3	$39	Hold	300	–	–	﹤0.01%	809
2022 Q2	$86	Hold	300	–	–	﹤0.01%	806
2022 Q1	$95	Hold	300	–	–	﹤0.01%	800
2021 Q4	$690	Hold	300	–	–	﹤0.01%	752
2021 Q3	$693	Hold	300	–	–	﹤0.01%	690
2021 Q2	$1.64K	Hold	300	–	–	﹤0.01%	539
2021 Q1	$1.57K	Hold	300	–	–	﹤0.01%	687
2020 Q4	$1.03K	Hold	300	–	–	﹤0.01%	662
2020 Q3	$591	Hold	300	–	–	﹤0.01%	617
2020 Q2	$771	Buy	+300	New	+$542	﹤0.01%	611

Other funds holding STAB

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Archer Investment Corporation's STAB Position: Q1 2023 in Review

Archer Investment Corporation sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 300 shares — an estimated $24 sold.

Archer Investment Corporation first reported a position in STAB in Q2 2020 and held it in 11 quarters. The position peaked at $1.64K in Q2 2021. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

Archer Investment Corporation reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Archer Investment Corporation sold 300 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $24.
Archer Investment Corporation first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
Archer Investment Corporation's Statera Biopharma, Inc. Common Stock position peaked at $1.64K in Q2 2021.
4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Archer Investment Corporation's 13F filing for Q1 2023, filed 9 May 2023.